Merocarb

Meropenem, the active ingredient in Merocarb, is a carbapenem presented as a sterile powder for reconstitution for intravenous use. It is employed to treat severe bacterial infections in hospitalized patients, particularly those caused by multidrug‑resistant organisms.

GNH USA supplies Merocarb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious infections that require intravenous therapy. - Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure in patients with perforated or necrotic abdominal conditions. - Complicated urinary tract infections: eliminates uropathogens, including resistant strains, to resolve infection. - Hospital‑acquired pneumonia: achieves lung tissue concentrations sufficient to treat Gram‑negative and Gram‑positive pathogens. - Septicemia: rapidly reduces bloodstream bacterial load, supporting hemodynamic recovery.

Adverse reactions may occur with any intravenous antibiotic and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: may be watery and self‑limiting. - Rash: localized skin erythema. - Elevated liver enzymes: transient increase in AST/ALT. - Headache: mild, often resolves without intervention.

Serious or Rare Side Effects: - Anaphylaxis: acute hypersensitivity requiring immediate medical attention. - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile colitis: severe diarrhea due to gut flora disruption. - Thrombocytopenia: reduced platelet count, monitor CBC. - Renal toxicity: elevated creatinine, adjust dosing as needed.

Meropenem should be used with caution in specific clinical situations. - Renal impairment: adjust dose based on creatinine clearance. - CNS disorders: monitor for neurotoxicity, especially seizures. - Pregnancy: safety not established; weigh benefits against potential risks. - Lactation: unknown excretion in breast milk; consider alternatives. - Hypersensitivity: avoid in patients with known carbapenem allergy. - Store at ambient temperature: keep in original container, protect from moisture and light.

Meropenem may interact with other agents, altering efficacy or safety.

Major Interactions (Avoid): - Valproic acid: concomitant use can reduce valproate levels and precipitate seizures. - Probenecid: may increase meropenem plasma concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxicity; monitor renal function. - Loop diuretics: potential additive ototoxicity; assess hearing if prolonged. - Anticoagulants: possible alteration of INR; check coagulation parameters.